.png)
NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
2931 Ridge Road Ste 101-1020 Rockwall, Texas 75032
+012 345 67890
LeadershipLending@gmail.com
Copyright © 2023 locksmith. All Rights Reserved
